Green tea, phytic acid, and inositol in combination reduced the incidence of azoxymethane-induced colon tumors in fisher 344 male rats

Journal of Medicinal Food

Volumn 14, Issue 11, 2011, Pages 1313-1320

  Khatiwada, Janak ^a   Verghese, Martha ^b   Davis, Shurrita ^a   Williams, Leonard L ^a  

^a NORTH CAROLINA A AND T STATE UNIVERSITY   (United States)

^b ALABAMA A AND M UNIVERSITY   (United States)

Author keywords

colon tumor; glutathione S transferase; green tea; inositol; phytic acid

Indexed keywords

AZOXYMETHANE; GLUTATHIONE TRANSFERASE; INOSITOL; PHYTIC ACID;

ACCLIMATIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; BODY WEIGHT; CANCER INCIDENCE; COLON TUMOR; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; FOOD INTAKE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; TEA;

ADMINISTRATION, ORAL; ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIOXIDANTS; AZOXYMETHANE; CARCINOGENS; COLON; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE TRANSFERASE; INOSITOL; MALE; PHYTIC ACID; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, INBRED F344; TEA;

RATTUS;

EID: 80755175239     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2010.0302     Document Type: Review

References (58)

1. Kuzuhara T, Suganuma M, Fujiki H: Green tea catechin as a chemical chaperone in cancer prevention. Cancer Lett 2008; 261:12-20.
2. Balentine DA, Wiseman SA, Bouwens LCM: The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 1997;37:693-704. (Pubitemid 127349613)
3. Janakun J, Selman SH, Swiercz R: Why drinking green tea could prevent cancer. Nature 1997;387:561. (Pubitemid 27248750)
4. Nagle DG, Ferreira D, Zhou, YD: Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives. Phytochemistry 2006;67:1849-1855. (Pubitemid 44291411)
5. Benelli R, Venè R, Bisacchi D, Garbisa S, Albini A: Antiinvasive effects of green tea polyphenol epigallocatechin-3- gallate (EGCG), a natural inhibitor of metallo and serine proteases. Biol Chem 2002;383:101-105. (Pubitemid 34224032)
6. Hara Y, Tonooka F: Hypotensive effect of tea catechins on blood pressure of rats [in Japanese]. Nippon Eiyo Shokuryo Gakkaishi 1990;43:345-348.
7. Kada T, Kaneo K, Matsuzaki S, Matsuzaki T, Hara Y: Detection and chemical identification of natural bioantimutagens. Mutat Res 1985;150:127-132.
8. Matsuzaki T, Hara Y: Antioxidative activity of tea leaf catechins. J Agric Chem Soc Jpn 1985;59:129-134.
9. Wang YC, Bachrach U: The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG). Amino Acids 2002; 22:131-143.
10. Hsu S: Green tea and the skin. J Am Acad Dermatol 2005;52: 1049-1059. (Pubitemid 40732543)
11. Muramatsu K, Fukuyo M, Hara Y: Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J Nutr Sci Vitaminol 1986;32:613-622.
12. Shimizu M, Wada S, Hayashi T, Arisawa M, Ikegaya K, Ogaku S, Yano S, Morita N: Studies of hypoglycemic constituents of Japanese tea. Yakugaku Zasshi 1988;108:964-970. (Pubitemid 18267213)
13. Yang CS, Lambert JD, Hou Z, Ju J, Lu G, Hao X: Molecular targets for the cancer preventive activity of tea polyphenols. Mol Carcinogen 2006;45:431-435. (Pubitemid 43865851)
14. Yang CS, Lambert JD, Ju J, Lu G, Sang S: Tea and cancer prevention: molecular mechanisms and human relevance. Toxicol Appl Pharmacol 2007;224:265-273. (Pubitemid 47592860)
15. Ahmad N, Gupta S. Mukhtar H: Green tea polyphenol epigallocatechin- 3-gallate differentially modulates nuclear factorjB in cancer cells versus normal cells. Arch Biochem Biophys 2000;376:338-346. (Pubitemid 30210882)
16. Cao Y, Cao R: Angiogenesis inhibited by drinking tea. Nature 1999;398:381.
17. Shenouda NS, Zhou C, Browning JD, Ansell PJ, Sakla MS, Lubahn DB, Macdonald RS: Phytoestrogens in common herbs regulate prostate cancer cell growth in vitro. Nutr Cancer 2004; 49:200-208. (Pubitemid 39487880)
18. Landau JM, Lambert JD, Lee MJ, Yang CS: Cancer Prevention by Tea and Tea Constituents. CRC Taylor and Francis, New York, 2005.
19. Ju J, Hong J, Zhou JN, Pan Z, Bose M, Liao J, Yang GY, Liu YY, Hou Z, Lin Y, Ma J, Shih WJ, Carothers AM, Yang CS: Inhibition of intestinal tumorigenesis in ApcMin/ + mice by ( - ) epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res 2005;65:10623-10631. (Pubitemid 41743758)
20. Ju J, Liu Y, Hong J, Huang MT, Conney AH, Yang CS: Effects of green tea and high-fat diet on arachidonic acid metabolism and aberrant crypt foci formation in an azoxymethane-induced colon carcinogenesis mouse model. Nutr Cancer 2003;46:172-178. (Pubitemid 37500509)
21. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A: Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a oneyear proof-of-principle study. Cancer Res 2006;66:1234-1240. (Pubitemid 43165995)
22. Kakuta Y, Nakaya N, Nagase S, Fujita M, Koizumi T, Okamura C, Niikura H, Ohmori K, Kuriyama S, Tase T, Ito K, Minami Y, Yaegashi N, Tsuji I: Case-control study of green tea consumption and the risk of endometrial endometroid adenocarcinoma. Cancer Causes Control 2009;20:617-624.
23. Clinical development plan: tea extracts. Green tea polyphenols. Epigallocatechin gallate. J Cell Biochem Suppl 1996;26: 236-257.
24. Fujiki H: Green tea: health benefits as cancer preventive for humans. Chem Rec 2005;5:119-132. (Pubitemid 41276860)
25. Shamsuddin AM, Vucenik I, Cole KE: IP6: a novel anti-cancer agent. Life Sci 1997;614:343-354.
26. Huang C, Ma WY, Hecht SS, Dong Z: Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting phosphatidylinositol-3' kinase. Cancer Res 1997;57: 2873-2878. Erratum in: Cancer Res 1997;57:5198.
27. Shamsuddin AM, Elsayed AM, Ullah A: Suppression of large intestinal cancer in F344 rats by inositol hexaphosphate. Carcinogenesis 1988;94:577-580.
28. Shamsuddin AM, Ullah A: Inositol hexaphosphate inhibits large intestinal cancer in F344 rats 5 months after induction by azoxymethane. Carcinogenesis 1989;10:625-626. (Pubitemid 19089937)
29. Saied IT, Shamsuddin AM: Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line. Anticancer Res 1998;18: 1479-1484. (Pubitemid 28342549)
30. Nelson RL, Yoo SJ, Tanure JC, Andrianopoulos GM: The effect of iron on experimental colorectal carcinogenesis. Anticancer Res 1989;9:1477-1482. (Pubitemid 20082116)
31. Reddy BS: Prevention of colon carcinogenesis by components of dietary fiber. Anticancer Res 1999;19:3681-3683.
32. Pretlow TP, O'Riordan MA, Pretlow TG: Aberrant crypts correlated with tumor incidence in fisher 344 male rats treated with azoxymethane and phytate. Carcinogenesis 1992;13:1509-1512.
33. Graf E, Eaton JW: Dietary suppression of colonic cancer: fiber or phytate? Cancer 1985;56:717.
34. Steinmetz KA, Kushi LH, Bostick RM, Folsom AR, Potter JD: Vegetables, fruit and colon cancer in the Iowa Women's Health Study. Am J Epidemiol 1994;139:1-15. (Pubitemid 24048061)
35. Greenward P, Lanza E, Eddy GA: Dietary fiber in the reduction of colon cancer risk. J Am Diet Assoc 1987;87:1178-1188.
36. Jariwalla RJ, Sabin R, Lawson S, Bloch DA, Prender M, Herman ZS: Effects of dietary phytic acid on the incidence and growth rate of tumors promoted in Fisher rats by a magnesium supplement. Nutr Res 1977;8:813.
37. Baten A, Ullah VJ, Tomazic T, Shamsuddin AM: Inositol phosphate induced enhancement of natural killer cell activity correlates with tumor suppression. Carcinogenesis 1989;10: 1597-1598.
38. Norazalina S, Norhaizan ME, Hairuszah I, Norashareena MS: Anticarcinogenic efficacy of phytic acid extracted from rice bran on azoxymethane-induced colon carcinogenesis in rats. Exp Toxicol Pathol 2010;62:259-268.
39. Challa A, Rao DR, Reddy B: Interactive suppression of aberrant crypt foci induced by azoxymethene in rat colon by phytic acid and green tea. Carcinogenesis 1997;18:2023-2026. (Pubitemid 28132391)
40. Laughlin LT, Bernat BA, Armstrong RN: Mechanistic imperative for the evolution of a metallo glutathione transferase of the vicinal oxygen chelate superfamily. Chem Biol Interact 1998; 111-112:41-50. (Pubitemid 28271933)
41. Pemble SE, Wardle AF, Taylor JB: Glutathione S-transferase class kappa: characterization by the cloning of rat mitochondrial GST and identification of a human homologue. Biochem J 1996; 319:749-754. (Pubitemid 26386186)
42. Panza VS, Wazlawik E, Ricardo Schütz G, Comin L, Hecht KC, da Silva EL: Consumption of green tea favorably affects oxidative stress markers in weighttrained men. Nutrition 2008;24: 433-442.
43. Habig WH, Pabst MJ, Jakoby WB: Glutathione S transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974;249:7130-7139.
44. Verghese M, Rao DR, Chawan, CB, Walker L.T, Shackelford L: Anticarcinogenic effect of phytic acid (IP6): apoptosis as a possible mechanism of action. Food Sci Technol 2006;39:1093-1098.
45. Reddy BS: Diet and colon cancer: evidence from human and animal model studies. In: Diet, Nutrition and Cancer: A Critical Evaluation, Vol. 1 (Reddy BS, Cohen LA, eds.). CRC Press, Inc., Boca Raton, FL, 1986, pp. 47-65.
46. Hirose M, Ozali K, Takabe K, Fukushima S, Shirai T, Ito N: Modifying effects of the naturally occurring c-oryzanol, phytic acid, tannic acid and n-tritricontane-16,18-dione in rat-a wide spectrum organ carcinogenesis model. Carcinogenesis 1991;12: 1917-1921.
47. Chen HW, Yang JJ, Tsai CW, Wu JJ, Sheen LY, Ou CC, Lii CK: Dietary fat and garlic oil independently regulate hepatic cytochrome P450 2B1 and the placental form of glutathione S-transferase expression in rats. J Nutr 2001;131:1438-1443.
48. Talalay P, Fahey JW, Holtzclaw WD, Prestera T, Zhang Y: Chemoprotection against cancer by phase 2 enzyme induction. Toxicol Lett 1995;82:173-179. (Pubitemid 26057505)
49. Hasegawa S, Miyake M: Biochemistry and biological functions of citrus limonoids. Food Rev Int 1996;12:413-435. (Pubitemid 126408313)
50. Hayes JD, Pulford D: The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995;30:445-600.
51. Ebert MN, Klinder A, Peters WH, Schaferhenrich A, Sendt W, Scheele J, Pool Zobel BL: Expression of glutathione S-transferases (GSTs) in human colon cells and inducibility of GSTM2 by butyrate. Carcinogenesis 2003;24:1637-1644. (Pubitemid 37304668)
52. Shamsuddin AM, Yang GY: Inositol hexaphosphate inhibits growth and induces differentiation of PC-3 human prostate cancer cell. Carcinogenesis 1995;16:1975-1979.
53. Shamsuddin AM, Baten A, Lalwani ND: Effects of inositol hexaphosphate on growth and differentiation in K562 erythroleukemia cell line. Cancer Lett 1992;64:195-202.
54. Vucenik I, Tomazic VJ, Fabian D, Shamsuddin AM: Antitumor activity of phytic acid in murine transplanted and metastatic fibrosarcoma, a pilot study. Cancer Lett 1992;65:9-13.
55. Wang ZY, Khan WA, Bickers DR, Mukhtar H: Protection against polycyclic aromatic hydrocarbon-induced skin tumor initiation in mice by green tea polyphenols. Carcinogenesis 1989;10:411-415. (Pubitemid 19050383)
56. Setiawan VW, Zhang ZF, Yu GP, Lu QY, Li YL: Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int J Cancer 2001;92:600-604. (Pubitemid 32319436)
57. Katiyar SK, Mukhtar H: Tea in chemoprevention of cancer: epidemiologic and experimental studies. Int J Oncol 1996;8: 221-238.
58. Kohlmeier L, Weterings KG, Steck S, Kok FJ: Tea and cancer prevention: an evaluation of the epidemiologic literature. Nutr Cancer 1997;27:1-13. (Pubitemid 26424309)